Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 36,145 shares at $130.42 ($4.8M) on 2018-01-04, disclosed to the SEC on 2018-01-08.
Open-market sale of $4.8M ALNY by VP, Finance and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.42 | 5,249 | $685K | 14.4% |
| 2 | $131.20 | 16,500 | $2.2M | 45.5% |
| 3 | $132.18 | 12,405 | $1.6M | 34.5% |
| 4 | $132.98 | 1,591 | $212K | 4.5% |
| 5 | $133.83 | 400 | $54K | 1.1% |
| Total | $131.53 avg | 36,145 |
| $4.8M |
| 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |